Gut Microbiome and Sex as Risk Factors for Kidney Stones After Bariatric Surgery
Launched by UNIVERSITY OF CHICAGO · Oct 15, 2020
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how diet and sex might influence the risk of developing kidney stones in people who are planning to have gastric bypass surgery. The study will involve participants following a specific diet provided by the clinic for six days and attending three visits at the research clinic. The goal is to gather information that could help understand how these factors affect kidney stone formation after surgery.
To participate, individuals must be between the ages of 18 and 75 and should not have a personal or family history of kidney stones. They should also be approved for surgery at the Bariatric Surgery Center at the University of Chicago Medicine. However, those with certain medical conditions, such as kidney disease or vitamin D deficiency, will not be eligible. If you join this study, you will help researchers learn important information that could benefit future patients undergoing bariatric surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants without history of stone disease, family history of stone disease
- • Participants pre-bariatric surgery who are approved and planned for surgery in the Bariatric Surgery Center at University of Chicago Medicine.
- Exclusion Criteria:
- • Patients with primary renal diseases or renal impairment (eGFR \< 90)
- • Patients with known bladder voiding problems
- • Patients with 25-vitamine D deficiency, as defined by level \< 25ng/mL
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Prochaska Megan, MD
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials